Human IL-13 Ra2 PharmaGenie ELISA Kit (SBRS0723)

The Human IL-13 Ra2 PharmaGenie ELISA from Assay Genie enables quantitative measurement of Interleukin-13 Receptor Alpha-2, a single-pass transmembrane receptor implicated in glioblastoma invasion, pancreatic ductal adenocarcinoma metastasis, and idiopathic pulmonary fibrosis. Investigators studying tumor microenvironment signaling, Th2-driven airway inflammation, and receptor decoy biology rely on this kit to quantify soluble receptor shed into cell culture supernatants, EDTA plasma, and serum from clinical cohorts. The assay employs a matched pair of monoclonal antibodies directed against extracellular epitopes of the human target, with no significant cross-reactivity observed with mouse, rat, or bovine orthologs. Reconstituted standards and detection antibody should be aliquoted and stored at -20°C, protected from light, with limited freeze-thaw tolerance to preserve activity. Intended for research use only, the kit supports biomarker validation, therapeutic target screening, and pathway analysis in vitro.